12-Chloro-10-(thiophen-2-yl)-7-thia-9,11-diazatricyclo[6.4.0.0,2,6]dodeca-1(12),2(6),8,10-tetraene

Catalog No. :
ACXSIP262
CAS No. :
851879-10-2
Molecular Formula :
C13H9ClN2S2
Molecular Weight :
292.82

IUPAC Name:4-chloro-2-(thiophen-2-yl)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine

12-Chloro-10-(thiophen-2-yl)-7-thia-9,11-diazatricyclo[6.4.0.0,2,6]dodeca-1(12),2(6),8,10-tetraene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$753.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name12-Chloro-10-(thiophen-2-yl)-7-thia-9,11-diazatricyclo[6.4.0.0,2,6]dodeca-1(12),2(6),8,10-tetraene
IUPAC Name4-chloro-2-(thiophen-2-yl)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine
MDL No.MFCD06655234
Molecular FormulaC13H9ClN2S2
Molecular Weight292.82
SMILESClC1=C2C3=C(SC2=NC(C4=CC=CS4)=N1)CCC3
InChI KeyKDXUPKMEPKGVPP-UHFFFAOYSA-N
Synonym5H-Cyclopenta[4,5]thieno[2,3-d]pyrimidine, 4-chloro-6,7-dihydro-2-(2-thienyl)-
CAS No.851879-10-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXSIP262 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXSIP262 route product structure diagram
    ACXSIP262851879-10-2
Inquiry

2. ACXSIP262 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0 In Stock
  4. Then
  5. ACXSIP262 route product structure diagram
    ACXSIP262851879-10-2
Inquiry

Comments (0)